Al Hamadi posts higher net profit at SAR 95.2m in I3 of 2014
30/09/2014
Argaam Exclusive
View other reports
Al Hamadi Investment Co. reported SAR 95.2m net profit at the end of the first nine months of 2014, a 22% increase compared to the same period last year, as shown in the following table:
Financials (M)
| Item | 9m 2013 | 9m 2014 | Change |
|---|---|---|---|
| Revenues | 309.94 | 352.53 | 13.7 % |
| Gross Income | 129.99 | 153.13 | 17.8 % |
| Operating Income | 77.76 | 96.43 | 24.0 % |
| Net Income | 78.21 | 95.24 | 21.8 % |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.49 | 0.60 | 21.8 % |
Compared With The
Current Quarter Comparison (M)
| Item | Q3 2013 | Q3 2014 | Change |
|---|---|---|---|
| Revenues | 96.26 | 108.83 | 13.1 % |
| Gross Income | 36.81 | 44.74 | 21.5 % |
| Operating Income | 19.02 | 24.77 | 30.3 % |
| Net Income | 18.32 | 25.42 | 38.7 % |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.11 | 0.16 | 38.7 % |
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| Q1 2014 | 122.04 | 16.4 % | 54.71 | 15.6 % | 35.96 | 19.5 % |
| Q2 2014 | 121.66 | 11.8 % | 53.68 | 17.1 % | 35.77 | 57.3 % |
| Q3 2014 | 108.83 | 13.1 % | 44.74 | 21.5 % | 24.77 | 30.3 % |
Profit Performance (Million)
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
|---|---|---|---|---|---|---|
| Q1 2014 | 34.23 | 14.7 % | 0.21 | - | 34.23 | 0.21 |
| Q2 2014 | 35.60 | 18.4 % | 0.22 | - | 35.60 | 0.22 |
| Q3 2014 | 25.42 | 38.7 % | 0.16 | - | 25.42 | 0.16 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2014 | 42.66 % | 27.85 % | 24.35 % |
| Q2 2014 | 43.18 % | 29.90 % | 26.17 % |
| Q3 2014 | 43.70 % | 30.34 % | 26.97 % |
Compared With The
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2014 | 160.00 | 0.72 | 0.69 | 3.87 |
| Q2 2014 | 160.00 | 0.76 | 0.76 | 7.88 |
| Q3 2014 | 160.00 | 0.80 | 0.80 | 8.04 |
Multiple Ratios (End of Period Price)
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2014 | - | - | - |
| Q2 2014 | - | - | - |
| Q3 2014 | 51.42 | 51.42 | 5.14 |
Business Segments (Million)
2014
| Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
|---|
| Current | |
| Market Cap (M Riyal) | 6,144.00 |
| Enterprise Value (EV) (M) | 5,905.92 |
| Shares Outstanding ((M)) | 160.00 |
| EPS ( Riyal) (TTM) | 2.04 |
| Book Value (BV) ( Riyal) | 12.11 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 23.23 |
| P/E (TTM) | 18.83 |
| Price/book | 3.17 |
| Return on Average Assets (%) (TTM) | 12.5 |
| Return on Average Equity (%) (TTM) | 17.3 |
Share Price
Al Hammadi Holding (ALHAMMADI)
Follow us on
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}